Related Experiment Video
Updated: May 29, 2025

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
Published on: December 13, 2024
Human iPSCs offer an alternative for modeling vascular malformation
Stefanie DeFronzo1, Guohao Dai1
1Department of Bioengineering, Northeastern University, Boston, MA 02115, USA.
Researchers created human induced pluripotent stem cell-derived venous endothelial cells (iVECs) to model venous malformations. TIE2-mutant iVECs successfully replicated disease pathogenesis, offering a new model for research and drug discovery.
Area of Science:
- Vascular biology
- Stem cell research
- Genetic disease modeling
Background:
- Venous malformations are complex vascular disorders.
- Current models for studying venous malformations are limited.
- Induced pluripotent stem cells (iPSCs) offer a potential source for patient-specific cell generation.
Purpose of the Study:
- To generate functional human venous endothelial cells from iPSCs.
- To create a disease model for venous malformations using iPSC-derived cells.
- To investigate the role of TIE2 mutations in venous malformation pathogenesis.
Main Methods:
- Generation of iPSC-derived venous endothelial cells (iVECs).
- Manipulation of cell-cycle dynamics and Notch signaling pathways.
- Introduction of TIE2 mutations into iVECs.
Main Results:
- Successfully generated iVECs with endothelial markers.
- TIE2-mutant iVECs exhibited characteristics recapitulating venous malformation pathogenesis.
- The study established a functional in vitro model for disease study.
Conclusions:
- iPSC-derived venous endothelial cells provide a valuable platform for studying venous malformations.
- The TIE2-mutant iVEC model facilitates mechanistic studies and potential drug screening.
- This approach advances the development of patient-specific disease models.
More Related Videos
06:36An In Vitro 3D Model and Computational Pipeline to Quantify the Vasculogenic Potential of iPSC-Derived Endothelial Progenitors
Published on: May 13, 2019
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Somatic...